UK Markets close in 5 hrs 43 mins
  • FTSE 100

    6,973.05
    +69.14 (+1.00%)
     
  • FTSE 250

    23,560.51
    +158.79 (+0.68%)
     
  • AIM

    1,261.11
    +6.11 (+0.49%)
     
  • GBP/EUR

    1.1664
    +0.0029 (+0.25%)
     
  • GBP/USD

    1.3689
    +0.0030 (+0.2204%)
     
  • BTC-GBP

    32,565.74
    -2,671.21 (-7.58%)
     
  • CMC Crypto 200

    1,084.17
    -50.21 (-4.43%)
     
  • S&P 500

    4,357.73
    -75.26 (-1.70%)
     
  • DOW

    33,970.47
    -614.41 (-1.78%)
     
  • CRUDE OIL

    71.35
    +1.06 (+1.51%)
     
  • GOLD FUTURES

    1,766.30
    +2.50 (+0.14%)
     
  • NIKKEI 225

    29,839.71
    -660.34 (-2.17%)
     
  • HANG SENG

    24,221.54
    +122.40 (+0.51%)
     
  • DAX

    15,337.05
    +204.99 (+1.35%)
     
  • CAC 40

    6,537.97
    +82.16 (+1.27%)
     

Global Over The Counter (OTC) Testing Market to Reach $27 Billion by 2027

·26-min read

Abstract: - Global Over The Counter (OTC) Testing Market to Reach $27 Billion by 2027. - Amid the COVID-19 crisis, the global market for Over The Counter (OTC) Testing estimated at US$14.

New York, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Over The Counter (OTC) Testing Industry" - https://www.reportlinker.com/p06032415/?utm_source=GNW
2 Billion in the year 2020, is projected to reach a revised size of US$27 Billion by 2027, growing at a CAGR of 9.6% over the analysis period 2020-2027. Glucose Monitoring Tests, one of the segments analyzed in the report, is projected to record a 9.5% CAGR and reach US$8.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Pregnancy & Fertility Tests segment is readjusted to a revised 10.2% CAGR for the next 7-year period.
- The U.S. Market is Estimated at $4.2 Billion, While China is Forecast to Grow at 9% CAGR
- The Over The Counter (OTC) Testing market in the U.S. is estimated at US$4.2 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$4.7 Billion by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.
- Infectious Disease Tests Segment to Record 10.8% CAGR
- In the global Infectious Disease Tests segment, USA, Canada, Japan, China and Europe will drive the 10.9% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.9 Billion in the year 2020 will reach a projected size of US$3.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$3.1 Billion by the year 2027.

- Select Competitors (Total 33 Featured) -

  • Abbott Laboratories

  • AccuBioTech

  • ACON Laboratories

  • bioLytical Laboratories

  • i-Health Lab

  • LabStyle Innovations

  • NOWDiagnostics Company

  • OraSure Technologies

  • Roche Diagnostics

  • SD Biosensor

  • Sinocare




Read the full report: https://www.reportlinker.com/p06032415/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Over The Counter
(OTC) Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 2: World Historic Review for Over The Counter (OTC)
Testing by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 3: World 15-Year Perspective for Over The Counter (OTC)
Testing by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets for Years 2012, 2020 & 2027

Table 4: World Current & Future Analysis for Glucose Monitoring
Tests by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 5: World Historic Review for Glucose Monitoring Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 6: World 15-Year Perspective for Glucose Monitoring Tests
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 7: World Current & Future Analysis for Pregnancy &
Fertility Tests by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 8: World Historic Review for Pregnancy & Fertility Tests
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 9: World 15-Year Perspective for Pregnancy & Fertility
Tests by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 10: World Current & Future Analysis for Infectious
Disease Tests by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 11: World Historic Review for Infectious Disease Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for Infectious Disease
Tests by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 13: World Current & Future Analysis for Coagulation
Monitoring Tests by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for Coagulation Monitoring
Tests by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 15: World 15-Year Perspective for Coagulation Monitoring
Tests by Geographic Region - Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World for Years 2012, 2020 & 2027

Table 16: World Current & Future Analysis for Urinalysis Tests
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 17: World Historic Review for Urinalysis Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for Urinalysis Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 19: World Current & Future Analysis for Cholesterol Tests
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 20: World Historic Review for Cholesterol Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 21: World 15-Year Perspective for Cholesterol Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 22: World Current & Future Analysis for Drugs-of-Abuse
Tests by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 23: World Historic Review for Drugs-of-Abuse Tests by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Drugs-of-Abuse Tests by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 25: World Current & Future Analysis for Other Test Types
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 26: World Historic Review for Other Test Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 27: World 15-Year Perspective for Other Test Types by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 28: World Current & Future Analysis for Immunoassays by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 29: World Historic Review for Immunoassays by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Immunoassays by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

Table 31: World Current & Future Analysis for Dipsticks by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2020 through 2027 and
% CAGR

Table 32: World Historic Review for Dipsticks by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 33: World 15-Year Perspective for Dipsticks by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2012, 2020 & 2027

Table 34: World Current & Future Analysis for Lateral Flow
Assays by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2020 through
2027 and % CAGR

Table 35: World Historic Review for Lateral Flow Assays by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2012 through 2019 and
% CAGR

Table 36: World 15-Year Perspective for Lateral Flow Assays by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

UNITED STATES
Table 37: USA Current & Future Analysis for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 38: USA Historic Review for Over The Counter (OTC)
Testing by Test Type - Glucose Monitoring Tests, Pregnancy &
Fertility Tests, Infectious Disease Tests, Coagulation
Monitoring Tests, Urinalysis Tests, Cholesterol Tests,
Drugs-of-Abuse Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 39: USA 15-Year Perspective for Over The Counter (OTC)
Testing by Test Type - Percentage Breakdown of Value Sales for
Glucose Monitoring Tests, Pregnancy & Fertility Tests,
Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 40: USA Current & Future Analysis for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 41: USA Historic Review for Over The Counter (OTC)
Testing by Technology - Immunoassays, Dipsticks and Lateral
Flow Assays Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 42: USA 15-Year Perspective for Over The Counter (OTC)
Testing by Technology - Percentage Breakdown of Value Sales for
Immunoassays, Dipsticks and Lateral Flow Assays for the Years
2012, 2020 & 2027

CANADA
Table 43: Canada Current & Future Analysis for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 44: Canada Historic Review for Over The Counter (OTC)
Testing by Test Type - Glucose Monitoring Tests, Pregnancy &
Fertility Tests, Infectious Disease Tests, Coagulation
Monitoring Tests, Urinalysis Tests, Cholesterol Tests,
Drugs-of-Abuse Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 45: Canada 15-Year Perspective for Over The Counter (OTC)
Testing by Test Type - Percentage Breakdown of Value Sales for
Glucose Monitoring Tests, Pregnancy & Fertility Tests,
Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 46: Canada Current & Future Analysis for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 47: Canada Historic Review for Over The Counter (OTC)
Testing by Technology - Immunoassays, Dipsticks and Lateral
Flow Assays Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 48: Canada 15-Year Perspective for Over The Counter (OTC)
Testing by Technology - Percentage Breakdown of Value Sales for
Immunoassays, Dipsticks and Lateral Flow Assays for the Years
2012, 2020 & 2027

JAPAN
Table 49: Japan Current & Future Analysis for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 50: Japan Historic Review for Over The Counter (OTC)
Testing by Test Type - Glucose Monitoring Tests, Pregnancy &
Fertility Tests, Infectious Disease Tests, Coagulation
Monitoring Tests, Urinalysis Tests, Cholesterol Tests,
Drugs-of-Abuse Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 51: Japan 15-Year Perspective for Over The Counter (OTC)
Testing by Test Type - Percentage Breakdown of Value Sales for
Glucose Monitoring Tests, Pregnancy & Fertility Tests,
Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 52: Japan Current & Future Analysis for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 53: Japan Historic Review for Over The Counter (OTC)
Testing by Technology - Immunoassays, Dipsticks and Lateral
Flow Assays Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 54: Japan 15-Year Perspective for Over The Counter (OTC)
Testing by Technology - Percentage Breakdown of Value Sales for
Immunoassays, Dipsticks and Lateral Flow Assays for the Years
2012, 2020 & 2027

CHINA
Table 55: China Current & Future Analysis for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 56: China Historic Review for Over The Counter (OTC)
Testing by Test Type - Glucose Monitoring Tests, Pregnancy &
Fertility Tests, Infectious Disease Tests, Coagulation
Monitoring Tests, Urinalysis Tests, Cholesterol Tests,
Drugs-of-Abuse Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 57: China 15-Year Perspective for Over The Counter (OTC)
Testing by Test Type - Percentage Breakdown of Value Sales for
Glucose Monitoring Tests, Pregnancy & Fertility Tests,
Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 58: China Current & Future Analysis for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 59: China Historic Review for Over The Counter (OTC)
Testing by Technology - Immunoassays, Dipsticks and Lateral
Flow Assays Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 60: China 15-Year Perspective for Over The Counter (OTC)
Testing by Technology - Percentage Breakdown of Value Sales for
Immunoassays, Dipsticks and Lateral Flow Assays for the Years
2012, 2020 & 2027

EUROPE
Table 61: Europe Current & Future Analysis for Over The Counter
(OTC) Testing by Geographic Region - France, Germany, Italy, UK
and Rest of Europe Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2020 through 2027 and % CAGR

Table 62: Europe Historic Review for Over The Counter (OTC)
Testing by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 63: Europe 15-Year Perspective for Over The Counter (OTC)
Testing by Geographic Region - Percentage Breakdown of Value
Sales for France, Germany, Italy, UK and Rest of Europe Markets
for Years 2012, 2020 & 2027

Table 64: Europe Current & Future Analysis for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 65: Europe Historic Review for Over The Counter (OTC)
Testing by Test Type - Glucose Monitoring Tests, Pregnancy &
Fertility Tests, Infectious Disease Tests, Coagulation
Monitoring Tests, Urinalysis Tests, Cholesterol Tests,
Drugs-of-Abuse Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 66: Europe 15-Year Perspective for Over The Counter (OTC)
Testing by Test Type - Percentage Breakdown of Value Sales for
Glucose Monitoring Tests, Pregnancy & Fertility Tests,
Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 67: Europe Current & Future Analysis for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 68: Europe Historic Review for Over The Counter (OTC)
Testing by Technology - Immunoassays, Dipsticks and Lateral
Flow Assays Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 69: Europe 15-Year Perspective for Over The Counter (OTC)
Testing by Technology - Percentage Breakdown of Value Sales for
Immunoassays, Dipsticks and Lateral Flow Assays for the Years
2012, 2020 & 2027

FRANCE
Table 70: France Current & Future Analysis for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 71: France Historic Review for Over The Counter (OTC)
Testing by Test Type - Glucose Monitoring Tests, Pregnancy &
Fertility Tests, Infectious Disease Tests, Coagulation
Monitoring Tests, Urinalysis Tests, Cholesterol Tests,
Drugs-of-Abuse Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 72: France 15-Year Perspective for Over The Counter (OTC)
Testing by Test Type - Percentage Breakdown of Value Sales for
Glucose Monitoring Tests, Pregnancy & Fertility Tests,
Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 73: France Current & Future Analysis for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 74: France Historic Review for Over The Counter (OTC)
Testing by Technology - Immunoassays, Dipsticks and Lateral
Flow Assays Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 75: France 15-Year Perspective for Over The Counter (OTC)
Testing by Technology - Percentage Breakdown of Value Sales for
Immunoassays, Dipsticks and Lateral Flow Assays for the Years
2012, 2020 & 2027

GERMANY
Table 76: Germany Current & Future Analysis for Over The
Counter (OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 77: Germany Historic Review for Over The Counter (OTC)
Testing by Test Type - Glucose Monitoring Tests, Pregnancy &
Fertility Tests, Infectious Disease Tests, Coagulation
Monitoring Tests, Urinalysis Tests, Cholesterol Tests,
Drugs-of-Abuse Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 78: Germany 15-Year Perspective for Over The Counter
(OTC) Testing by Test Type - Percentage Breakdown of Value
Sales for Glucose Monitoring Tests, Pregnancy & Fertility
Tests, Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 79: Germany Current & Future Analysis for Over The
Counter (OTC) Testing by Technology - Immunoassays, Dipsticks
and Lateral Flow Assays - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 80: Germany Historic Review for Over The Counter (OTC)
Testing by Technology - Immunoassays, Dipsticks and Lateral
Flow Assays Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 81: Germany 15-Year Perspective for Over The Counter
(OTC) Testing by Technology - Percentage Breakdown of Value
Sales for Immunoassays, Dipsticks and Lateral Flow Assays for
the Years 2012, 2020 & 2027

ITALY
Table 82: Italy Current & Future Analysis for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 83: Italy Historic Review for Over The Counter (OTC)
Testing by Test Type - Glucose Monitoring Tests, Pregnancy &
Fertility Tests, Infectious Disease Tests, Coagulation
Monitoring Tests, Urinalysis Tests, Cholesterol Tests,
Drugs-of-Abuse Tests and Other Test Types Markets - Independent
Analysis of Annual Sales in US$ Million for Years 2012 through
2019 and % CAGR

Table 84: Italy 15-Year Perspective for Over The Counter (OTC)
Testing by Test Type - Percentage Breakdown of Value Sales for
Glucose Monitoring Tests, Pregnancy & Fertility Tests,
Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 85: Italy Current & Future Analysis for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 86: Italy Historic Review for Over The Counter (OTC)
Testing by Technology - Immunoassays, Dipsticks and Lateral
Flow Assays Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2012 through 2019 and % CAGR

Table 87: Italy 15-Year Perspective for Over The Counter (OTC)
Testing by Technology - Percentage Breakdown of Value Sales for
Immunoassays, Dipsticks and Lateral Flow Assays for the Years
2012, 2020 & 2027

UNITED KINGDOM
Table 88: UK Current & Future Analysis for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 89: UK Historic Review for Over The Counter (OTC) Testing
by Test Type - Glucose Monitoring Tests, Pregnancy & Fertility
Tests, Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types Markets - Independent Analysis of Annual Sales
in US$ Million for Years 2012 through 2019 and % CAGR

Table 90: UK 15-Year Perspective for Over The Counter (OTC)
Testing by Test Type - Percentage Breakdown of Value Sales for
Glucose Monitoring Tests, Pregnancy & Fertility Tests,
Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 91: UK Current & Future Analysis for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays - Independent Analysis of Annual Sales in
US$ Million for the Years 2020 through 2027 and % CAGR

Table 92: UK Historic Review for Over The Counter (OTC) Testing
by Technology - Immunoassays, Dipsticks and Lateral Flow Assays
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2012 through 2019 and % CAGR

Table 93: UK 15-Year Perspective for Over The Counter (OTC)
Testing by Technology - Percentage Breakdown of Value Sales for
Immunoassays, Dipsticks and Lateral Flow Assays for the Years
2012, 2020 & 2027

REST OF EUROPE
Table 94: Rest of Europe Current & Future Analysis for Over The
Counter (OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 95: Rest of Europe Historic Review for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 96: Rest of Europe 15-Year Perspective for Over The
Counter (OTC) Testing by Test Type - Percentage Breakdown of
Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility
Tests, Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 97: Rest of Europe Current & Future Analysis for Over The
Counter (OTC) Testing by Technology - Immunoassays, Dipsticks
and Lateral Flow Assays - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 98: Rest of Europe Historic Review for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 99: Rest of Europe 15-Year Perspective for Over The
Counter (OTC) Testing by Technology - Percentage Breakdown of
Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays
for the Years 2012, 2020 & 2027

ASIA-PACIFIC
Table 100: Asia-Pacific Current & Future Analysis for Over The
Counter (OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 101: Asia-Pacific Historic Review for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 102: Asia-Pacific 15-Year Perspective for Over The
Counter (OTC) Testing by Test Type - Percentage Breakdown of
Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility
Tests, Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 103: Asia-Pacific Current & Future Analysis for Over The
Counter (OTC) Testing by Technology - Immunoassays, Dipsticks
and Lateral Flow Assays - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 104: Asia-Pacific Historic Review for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 105: Asia-Pacific 15-Year Perspective for Over The
Counter (OTC) Testing by Technology - Percentage Breakdown of
Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays
for the Years 2012, 2020 & 2027

REST OF WORLD
Table 106: Rest of World Current & Future Analysis for Over The
Counter (OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types - Independent
Analysis of Annual Sales in US$ Million for the Years 2020
through 2027 and % CAGR

Table 107: Rest of World Historic Review for Over The Counter
(OTC) Testing by Test Type - Glucose Monitoring Tests,
Pregnancy & Fertility Tests, Infectious Disease Tests,
Coagulation Monitoring Tests, Urinalysis Tests, Cholesterol
Tests, Drugs-of-Abuse Tests and Other Test Types Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2012 through 2019 and % CAGR

Table 108: Rest of World 15-Year Perspective for Over The
Counter (OTC) Testing by Test Type - Percentage Breakdown of
Value Sales for Glucose Monitoring Tests, Pregnancy & Fertility
Tests, Infectious Disease Tests, Coagulation Monitoring Tests,
Urinalysis Tests, Cholesterol Tests, Drugs-of-Abuse Tests and
Other Test Types for the Years 2012, 2020 & 2027

Table 109: Rest of World Current & Future Analysis for Over The
Counter (OTC) Testing by Technology - Immunoassays, Dipsticks
and Lateral Flow Assays - Independent Analysis of Annual Sales
in US$ Million for the Years 2020 through 2027 and % CAGR

Table 110: Rest of World Historic Review for Over The Counter
(OTC) Testing by Technology - Immunoassays, Dipsticks and
Lateral Flow Assays Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2012 through 2019 and % CAGR

Table 111: Rest of World 15-Year Perspective for Over The
Counter (OTC) Testing by Technology - Percentage Breakdown of
Value Sales for Immunoassays, Dipsticks and Lateral Flow Assays
for the Years 2012, 2020 & 2027

IV. COMPETITION
Total Companies Profiled: 33
Read the full report: https://www.reportlinker.com/p06032415/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting